^
Association details:
| Biomarker: | EGFR overexpression |
|---|---|
| Cancer: | Colorectal Cancer |
| Drug Class: | EGFR inhibitor |
| Direction: | Resistant |
Evidence:
Source:
Title:
Expression of podocalyxin-like protein and epidermal growth factor receptor in metastatic colorectal cancer: Prognostic impact and relationship with response to cetuximab.
Published date:
05/16/2018
Excerpt:
...454 mCRC patients from three Scandinavian countries...Both high expression of PODXL and EGFR was significantly associated with a reduced OS (HR = 1.86; 95% CI 1.29-2.69, and HR = 1.39; 95% CI 1.06-1.84, respectively)….
DOI:
10.1200/JCO.2018.36.15_suppl.e15587
